ICD-10-CM-2023 > C00-D49 > D37-D48 > D46 |
D37-D48 | Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes | |
Info: | Categories D37-D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made. | |
Excl1.: | neoplasms of unspecified behavior (D49.-) | |
D46 | Myelodysplastic syndromes | |
Use add'l | code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) | |
Excl2.: | drug-induced aplastic anemia (D61.1) | |
D46.0 | Refractory anemia without ring sideroblasts, so stated | |
Info: | Refractory anemia without sideroblasts, without excess of blasts | |
D46.1 | Refractory anemia with ring sideroblasts | |
Info: | RARS | |
D46.2 | Refractory anemia with excess of blasts [RAEB] | |
D46.20 | Refractory anemia with excess of blasts, unspecified | |
Info: | RAEB NOS | |
D46.21 | Refractory anemia with excess of blasts 1 | |
Info: | RAEB 1 | |
D46.22 | Refractory anemia with excess of blasts 2 | |
Info: | RAEB 2 | |
D46.A | Refractory cytopenia with multilineage dysplasia | |
D46.B | Refractory cytopenia with multilineage dysplasia and ring sideroblasts | |
Info: | RCMD RS | |
D46.C | Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality | |
Info: | Myelodysplastic syndrome with 5q deletion 5q minus syndrome NOS | |
D46.4 | Refractory anemia, unspecified | |
D46.Z | Other myelodysplastic syndromes | |
Excl1.: | chronic myelomonocytic leukemia (C93.1-) | |
D46.9 | Myelodysplastic syndrome, unspecified | |
Info: | Myelodysplasia NOS |
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |